Literature DB >> 21335003

Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma.

Havva Erdem1, Cemal Gündogdu, Sare Sipal.   

Abstract

Thyroid cancer represents approximately 1% of all human malignancies. papillary thyroid carcinoma (PTC) is the most common malignant tumor of the thyroid gland, accounting for 70-80% of all thyroid cancers. In the US, the incidence of thyroid cancer is 4 per 100,000 individuals. It is two to four times as frequent in women as in men. The development of PTC is influenced by many factors including genetic alterations, growth factors, and physical agents such as radiation. In order to recognize the prognosis for PTC, a lot of clinic and pathological parameters such as; age, tumor size, extra-thyroid tumor spread, lymph node, distant metastases, gender, tumor stage are used. As most of these parameters are subjective, more objective and useful prognostic factors are needed for determining biologic behavior, providing an initial assessment. In this study, we aimed to compare the expressions of COX-2, E-cadherin, VEGF to classical prognostic factors, and to investigate the correlation with prognosis. Operation records from 79 PTC cases were examined retrospectively. In the study, we aimed to investigate the whole tissue by means of stereology method, which is an impartial one, and we indicated the expression COX-2, VEGF, E-cadherin immunohistochemically in 79 resection diagnosed with PTC. We determined correlations between the expressions of COX-2 and VEGF, E-cadherin, and age, gender, and stage.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21335003     DOI: 10.1016/j.yexmp.2011.01.008

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  21 in total

1.  Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.

Authors:  Wen-Wu Dong; Jian Li; Jing Li; Ping Zhang; Zhi-Hong Wang; Wei Sun; Hao Zhang
Journal:  Int J Exp Pathol       Date:  2018-04-14       Impact factor: 1.925

2.  Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.

Authors:  İlknur Bingül; Pervin Vural; Semra Doğru-Abbasoğlu; Esra Çil; Müjdat Uysal
Journal:  J Clin Lab Anal       Date:  2016-12-07       Impact factor: 2.352

3.  Expression of prostaglandin E2 and EP receptors in human papillary thyroid carcinoma.

Authors:  Liao Sun; Xiaohong Wei; Xueting Liu; Danli Zhou; Fang Hu; Yingjuan Zeng; Ying Sun; Shunkui Luo; Yu Zhang; Xian Ping Yi
Journal:  Tumour Biol       Date:  2015-10-28

4.  BRAF and epithelial-mesenchymal transition in papillary thyroid carcinoma - challenging the roles of Snail and E-Cadherin?

Authors:  Brendon Mitchell; Dominick Leone; Shi Yang; Ashraf Khan; Meera Mahalingam; Jagdish Dhingra
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

5.  Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma.

Authors:  Baoqing Jia; Hongyi Liu; Qinglong Kong; Bing Li
Journal:  Mol Cell Biochem       Date:  2012-03-31       Impact factor: 3.396

6.  Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.

Authors:  Ayşe Bahar Ceyran; Serkan Şenol; Bengü Çobanoğlu Şimşek; Julide Sağıroğlu; Abdullah Aydın
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

7.  Relationship between VEGF protein expression and lymph node metastasis in papillary thyroid carcinoma among Asians: a meta-analysis.

Authors:  De-Feng Chang; Zhong-Qing Xu; Bin Sun
Journal:  Tumour Biol       Date:  2014-02-21

8.  Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma.

Authors:  Jiaxing Zhang; Chenhui Lu; Jun Zhang; Jiuhong Kang; Chuanwu Cao; Maoquan Li
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

9.  Expressions of D2-40, CK19, galectin-3, VEGF and EGFR in papillary thyroid carcinoma.

Authors:  Lei Gong; Ping Chen; Xianjun Liu; Ying Han; Yanping Zhou; Weidong Zhang; Hong Li; Chuanjia Li; Jiang Xie
Journal:  Gland Surg       Date:  2012-05

10.  Relationship between expression of vascular endothelial growth factor and cervical lymph node metastasis in papillary thyroid cancer: A meta-analysis.

Authors:  Xiao-Qing Huang; Wen-Shan He; Hui-Qiong Zhang; Rui Yang; Tao Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.